- Innovus Pharma Announces Initiation of a Clinical Study to Evaluate the Tolerance and the Effect of Musclin™ on Muscle Health in Adults in the United States
- Innovus Pharmaceuticals Acquires Worldwide Rights to Four Products from Boston Topicals, LLC
- Innovus Pharma Reports Another New Quarterly Revenue Record of Approximately $7.4 Million for the Third Quarter 2018 and $19.2 Million for the First Nine Months of 2018
- Innovus Pharmaceuticals to Release Its Third Quarter 2018 Financial Results on Wednesday, November 14, 2018
- Innovus Pharmaceuticals Reports Preliminary Q3 2018 Sales Revenue of $7.0 million to $7.1 million
- Innovus Pharma Receives Approval for Medicare Reimbursement for its GlucoGorx™ Blood Glucose Monitoring System and GlucoGorx™ Blood Glucose Test Strip Products
- Innovus Pharma Announces Planned Expansion into CBD Oil-Based Products Market
- Innovus Pharma Receives Approval from Amazon® to Expand its Amazon® Stores to Japan
Innovus Pharmaceuticals Inc (INNV:QBB) closed at 0.0989, 23.63% above the 52 week low of 0.08 set on Jan 03, 2018.
0.08Jan 03 20180.21Feb 21 2018
Markit short selling activity
|Market cap||20.34m USD|
|EPS (TTM)||-0.0387 |
Data delayed at least 15 minutes, as of Dec 13 2018 20:01 GMT.